Related references
Note: Only part of the references are listed.Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma
Anna Bold et al.
JOURNAL OF IMMUNOTHERAPY (2023)
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells
Justin C. Boucher et al.
JOURNAL OF IMMUNOTHERAPY (2023)
Report Phosphoantigen sensing combines TCR-dependent recognition of the BTN3A IgV domain and germline interaction with BTN2A1
Carrie R. Willcox et al.
CELL REPORTS (2023)
Dissecting the cellular components of ex vivo γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials
Hunter C. Jonus et al.
ONCOIMMUNOLOGY (2022)
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
Yan Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid
Haeyoun Choi et al.
CYTOTHERAPY (2021)
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
Gitte Holmen Olofsson et al.
FRONTIERS IN IMMUNOLOGY (2021)
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
Mahboubeh Yazdanifar et al.
CELLS (2020)
Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet
Pia Aehnlich et al.
FRONTIERS IN IMMUNOLOGY (2020)
Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
Rebecca E. Burnham et al.
FRONTIERS IN MEDICINE (2020)
Allogenic V9V2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies
Timm Hoeres et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Optimized protocols for T cell expansion and lentiviral transduction
Rui-Ning Wang et al.
MOLECULAR MEDICINE REPORTS (2019)
PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia
Timm Hoeres et al.
ONCOIMMUNOLOGY (2019)
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
Lin Xiao et al.
CYTOTHERAPY (2018)
Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
Timm Hoeres et al.
FRONTIERS IN IMMUNOLOGY (2018)
Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
Myriam Lawand et al.
FRONTIERS IN IMMUNOLOGY (2017)
Enhancing adoptive cancer immunotherapy with VΥ2Vδ2 T cells through pulse zoledronate stimulation
Mohanad H. Nada et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Bioengineering and serum free expansion of blood-derived γδT cells
Kathryn S. Sutton et al.
CYTOTHERAPY (2016)
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
Heleen H. Van Acker et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Indirect Stimulation of Human Vγ2Vδ2 T Cells through Alterations in Isoprenoid Metabolism
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2011)
Vγ9Vγ2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Matilde D'Asaro et al.
JOURNAL OF IMMUNOLOGY (2010)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
V gamma 9V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab
Hirotake Tokuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model
H Sicard et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
γδ T cells provide an early source of interferon γ in tumor immunity
YF Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Lack of CD27-CD45RA-Vγ9Vδ2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis
C Gioia et al.
JOURNAL OF IMMUNOLOGY (2002)
Gamma/delta T lymphocytes are affected in the elderly
G Colonna-Romano et al.
EXPERIMENTAL GERONTOLOGY (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Antigen recognition by human γδ T cells:: pattern recognition by the adaptive immune system
CT Morita et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)
Share Paper
